ADD-ON THERAPY WITH TOPIRAMATE IN DRUG-RESISTANT EPILEPSY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FALAH R.; GHOFRANI M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Research in Medicine Year:2005 | Volume:29 | Issue:2 Page(s): 147-152

Download Full-Text

Persian Verion

View:

878

Download:

Cites:

Information Journal Paper

Title

ADD-ON THERAPY WITH TOPIRAMATE IN DRUG-RESISTANT EPILEPSY

Author(s)

FALAH R. | GHOFRANI M. | Issue Writer Certificate

Keywords

INTRACTABLE EPILEPSYQ3

TOPIRAMATEQ4

ADD-ON THERAPYQ4

Abstract

Background: INTRACTABLE EPILEPSY is defined as epilepsies that are not controlled with routine pharmacologic therapy. The present study was conducted to evaluate the efficacy and side effects of TOPIRAMATE as an ADD-ON THERAPY in drug-resistant (intractable) epilepsies. Materials and methods: For this quasi experimental study 42 children who have referred to Mofid hospital with refractory epilepsy were enrolled. The study population included 14 girls and 28 boys, aged 1-15 years. Seizure attacks were not controlled despite receiving 4-13 drugs (mean 9). TOPIRAMATE was added to the patients drug in a 4-week titration regimen (1st week 3, 2nd week 5, 3rd week 7, and 4th week 9 mg/kg). Then, after 3 months he/she was reevaluated.Results: Of 42 patients, Lennox-Gastaut syndrome, idiopathic epilepsy, symptomatic epilepsy, and progressive myoclonic epilepsy were revealed in 14 (34%), 8(19%), 16(38%), and 4(9%), respectively. After the 3-month ADD-ON THERAPY with TOPIRAMATE, 17% became seizure-free and the frequency of seizure attacks decreased by 50% in 26% of the patients, however, attacks were exacerbated in 5%. Fortunately, hematologic, renal or hepatic side effects were not reported, however, mild transient neurologic complications were observed in 12% of the patients.Conclusion: We have noticed a satisfactory response to TOPIRAMATE, thus, it can be safely prescribed for intractable seizures.

Cites

No record.

References

No record.

Cite

APA: Copy

FALAH, R., & GHOFRANI, M.. (2005). ADD-ON THERAPY WITH TOPIRAMATE IN DRUG-RESISTANT EPILEPSY. PAJOUHESH DAR PEZESHKI, 29(2), 147-152. SID. https://sid.ir/paper/42015/en

Vancouver: Copy

FALAH R., GHOFRANI M.. ADD-ON THERAPY WITH TOPIRAMATE IN DRUG-RESISTANT EPILEPSY. PAJOUHESH DAR PEZESHKI[Internet]. 2005;29(2):147-152. Available from: https://sid.ir/paper/42015/en

IEEE: Copy

R. FALAH, and M. GHOFRANI, “ADD-ON THERAPY WITH TOPIRAMATE IN DRUG-RESISTANT EPILEPSY,” PAJOUHESH DAR PEZESHKI, vol. 29, no. 2, pp. 147–152, 2005, [Online]. Available: https://sid.ir/paper/42015/en

Related Journal Papers